October 7, 2021

Successful Development of Scalable AAV Processes: Part 2 of 2

Watch the Q&A interview >>

In the second of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Production, and Åsa Hagner-McWhirter, PhD, Senior Scientist, Bioprocess Applications R&D, both at Cytiva, discuss upstream and downstream strategies for successful adeno-associated virus (AAV) production.

Tags: AAV; adeno-associated virus; process development; upstream; downstream